---
title: "Artelo Biosciences (ARTL.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ARTL.US/norm.md"
symbol: "ARTL.US"
name: "Artelo Biosciences"
parent: "https://longbridge.com/zh-CN/quote/ARTL.US.md"
datetime: "2026-05-21T23:17:48.266Z"
locales:
  - [en](https://longbridge.com/en/quote/ARTL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ARTL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ARTL.US/norm.md)
---

# Artelo Biosciences (ARTL.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -4.00 | -6.18 | -11.89 | -16.83 | -13.01 |
| ROE | -438.22% | 1749.50% | 1224.13% | 3417.51% | -540.78% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.96M | -4.17M | -3.12M | -3.22M | -2.37M |
| 营业利润 | -2.69M | -2.79M | -3.09M | -3.15M | -2.38M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 12.52M | 2.80M | 4.27M | 4.36M | 3.52M |
| 权益乘数 | 1.88 | -2.20 | -6.74 | -3.10 | 5.39 |
| 每股净资产 | 7.62 | -1.89 | -1.22 | -5.99 | 3.58 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 10.27M | 600000.00 | 1.72M | 2.07M | 746000.00 |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 55000.00 | 64000.00 | 73000.00 | 82000.00 | 91000.00 |
| 净债务 | -9.55M | 78000.00 | -766000.00 | -1.19M | -651000.00 |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.19M | -2.91M | -3.50M | -514000.00 | -1.60M |
| 投资现金流 | - | 188000.00 | -250000.00 | - | - |
| 融资现金流 | 10.86M | 1.61M | 3.44M | 1.82M | - |
| 自由现金流 | -1625.00 | -1.91M | -2.38M | 768250.00 | -680875.00 |
| 现金流充裕率 | - | -12129.17% | - | - | - |
| 举债与偿债 | 593000.00 | -129000.00 | 0.0000 | 737000.00 | - |
| 资本支出 | - | - | - | - | - |